rethinkTHC Search
Menu
Study breakdown

Edible and flower cannabis users showed similar intoxication and memory impairment despite different blood THC levels

ObservationalModerate evidence
The takeaway

In a naturalistic study of 84 legal-market cannabis users, flower users had higher blood THC levels but similar THC metabolite levels, subjective intoxication, and verbal memory impairment compared to edible users.

Cannabis users, clinicians, and researchers interested in how different cannabis forms compare in real-world use.

Similar impairment despite 3x dose difference between flower and edible users

What the researchers found

Flower users consumed an average of 51.25 mg THC vs. 15.97 mg for edible users. Plasma THC was significantly higher after flower use, but THC metabolite levels, subjective intoxication, and verbal memory impairment were comparable between groups. Self-reported THC consumed correlated strongly with plasma THC for edible but not flower users.

Why it matters

This is one of the first studies to directly compare the pharmacology and effects of legal market edible and flower cannabis under naturalistic conditions, providing data more relevant to real-world use than laboratory studies with standardized products.

The numbers in context

84 participants; flower users consumed 51.25 mg THC on average vs. 15.97 mg for edible users. Similar levels of intoxication and verbal memory impairment despite the dose difference.

How the study worked

Naturalistic study of 84 participants (55 flower, 29 edible users, mean age 32, 44% female) who used cannabis at least once weekly. Participants underwent blood draws, heart rate measurement, subjective drug effects assessment, and cognitive testing before and after ad libitum use of legal market products in a mobile laboratory.

What this study cannot tell us

Non-randomized design (participants self-selected their product type). Unequal group sizes. Ad libitum dosing means results reflect typical use patterns rather than controlled comparisons. Single-session assessment.

How to read the evidence

Novel naturalistic design with legal market products, but non-randomized and moderate sample size.

When this study was published

Published in 2022.

The bigger picture

The finding that edible and flower users reach similar levels of impairment despite different doses and blood levels challenges simplistic dose-response assumptions and highlights the complexity of cannabis pharmacology across delivery methods.

Questions still open

  • Why do edible users achieve similar impairment with lower doses? Does tolerance develop differently for each route? Could edible dosing guidelines be based on these naturalistic findings?

Common questions

Do edibles and flower produce different levels of impairment?
In this study, despite flower users consuming about three times more THC (51 mg vs. 16 mg), both groups showed similar levels of subjective intoxication and verbal memory impairment after ad libitum use.
Why did edible users consume less THC but feel equally intoxicated?
Edible users may titrate their dose more effectively to reach their desired effect, or the metabolic pathway for oral THC (which produces the potent metabolite 11-OH-THC) may produce comparable effects at lower doses.

Read the original research

A naturalistic study of orally administered vs. inhaled legal market cannabis: cannabinoids exposure, intoxication, and impairment.

Psychopharmacology, 239(2), 385-397

Citation

Bidwell, L Cinnamon; Karoly, Hollis C; Torres, Marco Ortiz; Master, Ashley; Bryan, Angela D; Hutchison, Kent E. (2022). A naturalistic study of orally administered vs. inhaled legal market cannabis: cannabinoids exposure, intoxication, and impairment.. Psychopharmacology, 239(2), 385-397. https://doi.org/10.1007/s00213-021-06007-2

Explore the wider topic